Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells (Q39995957)

16 September 2017

title

Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells (English)

1 reference

16 September 2017

1 reference

1 reference

8

Giovanni Martinelli

1 reference

16 September 2017

7

Michele Baccarani

1 reference

16 September 2017

6

Sergio Storti

1 reference

16 September 2017

2

Michela Palmisano

1 reference

16 September 2017

1

Tiziana Grafone

1 reference

16 September 2017

3

Chiara Nicci

1 reference

16 September 2017

author name string

Alberto Maria Martelli

series ordinal

4

1 reference

16 September 2017

Ottaviani Emanuela

series ordinal

5

1 reference

16 September 2017

language of work or name

1 reference

1 September 2008

1 reference

16 September 2017

published in

Hematological Oncology

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

159-166

1 reference

describes a project that uses

16 September 2017

1 reference

FLT3 mutations: biology and treatment

1 reference

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

7 January 2021

FLT3: ITDoes matter in leukemia

1 reference

7 January 2021

Role of FLT3 in leukemia

1 reference

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

7 January 2021

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

1 reference

7 January 2021

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

7 January 2021

Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.

1 reference

7 January 2021

Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods

1 reference

7 January 2021

The structural basis for autoinhibition of FLT3 by the juxtamembrane domain

1 reference

7 January 2021

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

1 reference

7 January 2021

Novel FLT3 tyrosine kinase inhibitors

1 reference

7 January 2021

Developing target therapy against oncogenic tyrosine kinase in myeloid maliganacies

1 reference

7 January 2021

Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling

1 reference

7 January 2021

Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.

1 reference

7 January 2021

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry

1 reference

7 January 2021

Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level

1 reference

7 January 2021

Single cell profiling of potentiated phospho-protein networks in cancer cells.

1 reference

7 January 2021

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia

1 reference

7 January 2021

Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.

1 reference

7 January 2021

Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.854

1 reference

16 September 2017

1 reference